France· FR:67652999
VIZAMYL 400 MBq/ml, solution injectable
A flutemetamol (18f) product containing flutémétamol (18f), registered in France by GE HEALTHCARE (NORVEGE). The same ATC class is registered in 9 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Flutemetamol (18f) is registered in 9 of 19 countries.
Countries holding a registration under ATC V09AX04 (flutemetamol (18f)), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 7 of them publish a price we can compare per daily dose
Flutemetamol (18f) · ATC V09AX04
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FLUTÉMÉTAMOL (18F)
- Manufacturer
- GE HEALTHCARE (NORVEGE)
- Country
- France (FR)
- ATC code
- V09AX04
- ATC class
- Flutemetamol (18F)
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550002041 flacon(s) en verre de 15 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flutemetamol (18f) in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVIZAMYLGE Healthcare AS, Oslo
- SpainVIZAMYL 400 MBq/ml solucion inyectable Flutemetamol (18F)Ge Healthcare As
- FinlandVizamylGE Healthcare AS
- IrelandVIZAMYL 400 MBq/mL solution for injectionGE Healthcare AS
- NetherlandsVIZAMYL 400 MBq/ml oplossing voor injectieGE Healthcare AS
- SwedenVIZAMYL 400 MBq/ml Injektionsvätska, lösningGE Healthcare AS
- United StatesVizamylGE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Vizamyl
- Iceland · Vizamyl
- Liechtenstein · Vizamyl
- Norway · Vizamyl
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e3b40d92-5e4a-49d7-b31c-607926235799 GET /v1/drugs/e3b40d92-5e4a-49d7-b31c-607926235799?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67652999",
"date_amm": "2014-08-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/941",
"substance": "FLUTÉMÉTAMOL (18F)",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about flutemetamol (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.